MDM4 and non-small cell lung carcinoma: The principal finding of this trial is that two SNPs (rs10900598 and rs4245739), located at 3′-UTR of MDM4 gene, contribute to clinical outcome of advanced NSCLC patients treated with platinum-based chemotherapy.